The BRAF-mutation-like subtype represents approximately 20% of colorectal cancers patients, of which ~10% are known BRAF mutated tumors and ~10% are BRAF wild-type tumors that share the same gene expression pattern. The gene discussed is BRAF; the disease is colorectal cancer.